Morschhauser F, Nastoupil L, Feugier P, Schiano de Colella JM, et al. Six-Year Results From RELEVANCE: Lenalidomide Plus Rituximab (R(2)) Versus Rituximab-Chemotherapy Followed by Rituximab Maintenance in Untreated Advanced Follicular Lymphoma. J Clin Oncol 2022 Aug 10:JCO2200843. doi: 10.1200/JCO.22.00843.
PMID: 35947804